Vanda Pharmaceuticals
VNDA
#8241
Rank
NZ$0.53 B
Marketcap
NZ$8.91
Share price
-3.36%
Change (1 day)
14.17%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$0.26 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's total liabilities are NZ$0.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vanda Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$0.27 B33.88%
2024-12-31NZ$0.20 B27.44%
2023-12-31NZ$0.16 B-2.9%
2022-12-31NZ$0.16 B29.6%
2021-12-31NZ$0.13 B17.06%
2020-12-31NZ$0.11 B2.81%
2019-12-31NZ$0.10 B27.87%
2018-12-31NZ$84.54 M-18.9%
2017-12-31NZ$0.10 B-8.64%
2016-12-31NZ$0.11 B-2.4%
2015-12-31NZ$0.11 B741.46%
2014-12-31NZ$13.89 M-88.49%
2013-12-31NZ$0.12 B-20.88%
2012-12-31NZ$0.15 B-20.14%
2011-12-31NZ$0.19 B-15.93%
2010-12-31NZ$0.22 B-18.54%
2009-12-31NZ$0.27 B4037.9%
2008-12-31NZ$6.74 M-60.66%
2007-12-31NZ$17.14 M27.09%
2006-12-31NZ$13.48 M81.21%
2005-12-31NZ$7.44 M193.68%
2004-12-31NZ$2.53 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$206.01 B 78,263.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$137.00 B 52,011.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$201.72 B 76,630.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$146.93 B 55,790.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$142.41 B 54,072.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$114.22 B 43,349.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
NZ$0.45 M-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA